New Affordable HIV-Prevention Injection Advances: India’s Dr. Reddy’s Gets FDA Nod for…
A twice-yearly HIV-prevention injection could become more accessible to millions as Indian pharmaceutical company Dr. Reddy's Laboratories secures tentative US FDA approval for a generic version of lenacapavir. The proposed price of around…
Read More...
Read More...